The Health Research Authority (HRA) has published the findings from its pilot on researchers and sponsors of clinical trials and clinical investigations developing and submitting an Inclusion and Diversity Plan. This initiative aims to enhance the representation of diverse populations in clinical research, which could lead to more equitable healthcare outcomes. By focusing on inclusion and diversity, the HRA is addressing a critical aspect of clinical trial design that may influence the effectiveness and applicability of new treatments across different demographic groups.
Source: gov.uk · Image: Naitō Museum of Pharmaceutical Science and Industry 20210529 32 by 先従隗始, CC0, via Wikimedia Commons
Planning your supply chain?
The API & FDF Intelligence database shows where manufacturers are located, which certificates they hold, and which markets are overheated.
With direct contacts for every supplier and holder, you can move from weeks of outreach to decisions made in hours.
Use the database as your supply chain compass →
Use the database as your supply chain compass →
